Dr Christa Dang
Research Fellow - The Mind Study
Department of General Practice and Primary Care
37 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Clarifications and response to “Validating plasma biomarkers for distinguishing neurodegenerative and psychiatric disorders” by Boccardi et al.
DOI: 10.1002/alz.713752025
Journal article
Transforming dementia diagnostics and care: developing anovel, cost-effective technology to facilitate widespread andcost-effective clinical implementation of neurofilament lightand other biomarkers
DOI: 10.1002/alz70856_1019302025
Journal article
Mindful Moderation: Differential Relationships Between Psychological Distress and NfL, GFAP and p ‐tau217 by Diagnostic Group
DOI: 10.1002/alz70856_1060102025
Journal article
Apathy and Affective Symptoms are Associated with Elevated Alzheimer’s Disease Biomarkers
DOI: 10.1002/alz70856_1027212025
Journal article
Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic
DOI: 10.1002/alz.707172025
Journal article
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease
DOI: 10.1002/dad2.701512025
Journal article
Understanding the consumer, carer and stakeholder experiences of residential respite care
DOI: 10.1111/ajag.13404
RECENT SCHOLARLY WORKS
2025
Journal article
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
DOI: 10.1007/s00415-024-12732-32024
Journal article
Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders
DOI: 10.1016/j.jns.2024.1232912024
Journal article
The Markers in Neuropsychiatric Disorders Study (The MiND Study): progress of a large nationwide Australian blood biomarker study and platform for collaborations to improve diagnosis and care of dementia and other brain conditions
DOI: 10.1002/alz.088415